Skip to content
DataLookout
Menu

NCT07899827

Studying Different Ways of Using Oral Nicotine Pouches to Understand the Effect on Nicotine Delivery, Appeal, and Side Effects Among Adult Cigarette Smokers

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Plasma Nicotine Pharmacokinetics (Cmax)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Plasma Nicotine Pharmacokinetics (Tmax)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Plasma Nicotine Pharmacokinetics (AUC_0-90)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Product Liking
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Product Appeal (mCEQ)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Behavioral Economic Demand
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Craving Relief (QSU)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Relief of Withdrawal Symptoms (MNWS)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Intensity of Sensory Attributes (gLMS)
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Behavioral Intentions
Timeframe: At laboratory visits 2, 3, and 4, assessed up to 1 month
Incidence of Adverse Effects
Timeframe: Up to 1 month

Arms and interventions

Condition Order 1 (upper lip, lower lip, ad libitum)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 1: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP for 30 minutes with placement between the upper lip and gum; Laboratory visit 2) Participants use study ONP for 30 minutes with placement between the lower lip and gum; and Laboratory visit 3) Participants use study ONP with ad libitum use for 30 minutes. Additionally, patients undergo blood sample collection on study.

Condition Order 2 (upper lip, ad libitum, lower lip)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 2: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP for 30 minutes with placement between the upper lip and gum; Laboratory visit 2) Participants use study ONP with ad libitum use for 30 minutes; and Laboratory visit 3) Participants use study ONP for 30 minutes with placement between the lower lip and gum. Additionally, patients undergo blood sample collection on study.

Condition Order 3 (lower lip, upper lip, ad libitum)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 3: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP for 30 minutes with placement between the lower lip and gum; Laboratory visit 2) Participants use study ONP for 30 minutes with placement between the upper lip and gum; and Laboratory visit 3) Participants use study ONP with ad libitum use for 30 minutes. Additionally, patients undergo blood sample collection on study.

Condition Order 4 (lower lip, ad libitum, upper lip)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 4: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP for 30 minutes with placement between the lower lip and gum; Laboratory visit 2) Participants use study ONP with ad libitum use for 30 minutes; and Laboratory visit 3) Participants use study ONP for 30 minutes with placement between the upper lip and gum. Additionally, patients undergo blood sample collection on study.

Condition Order 5 (ad libitum, upper lip, lower lip)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 5: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP with ad libitum use for 30 minutes; Laboratory visit 2) Participants use study ONP for 30 minutes with placement between the upper lip and gum; and Laboratory visit 3) Participants use study ONP for 30 minutes with placement between the lower lip and gum. Additionally, patients undergo blood sample collection on study.

Condition Order 6 (ad libitum, lower lip, upper lip)Experimental

SAMPLING WEEK: Participants receive study ONP and complete at-home sampling of ONPs for 1 week in the absence of unacceptable toxicity. CONDITION ORDER 6: Following at-home sampling week, participants then attend three laboratory visits in the absence of unacceptable toxicity which consist of the following: Laboratory visit 1) Participants use study ONP with ad libitum use for 30 minutes; Laboratory visit 2) Participants use study ONP for 30 minutes with placement between the lower lip and gum; and Laboratory visit 3) Participants use study ONP for 30 minutes with placement between the upper lip and gum. Additionally, patients undergo blood sample collection on study.

Procedures: Biospecimen Collection

Drugs: Oral nicotine pouches

Other: Survey Administration

Sites

1 site in 1 country

  • Ohio State University Comprehensive Cancer CenterColumbus, Ohio, United States